Glucovance 250mg/1.25mg Tablets – Metformin & Glibenclamide for Type 2 Diabetes Control

Drug Class: Biguanide + Sulfonylurea Combination Antidiabetic | Form: Oral Tablet | Prescription Status: Prescription Only (Rx)

What Is Glucovance 250mg/1.25mg?

Glucovance 250mg/1.25mg is a prescription fixed-dose combination antidiabetic tablet containing two complementary blood sugar-lowering medicines in a single tablet — Metformin Hydrochloride 250mg and Glibenclamide (Glyburide) 1.25mg. Each ingredient belongs to a different antidiabetic drug class and works through a completely different mechanism — Metformin reduces the amount of glucose the liver produces and improves the body's sensitivity to insulin, while Glibenclamide stimulates the pancreas to produce more insulin. Together they address type 2 diabetes from two separate and complementary directions simultaneously — producing greater blood sugar reduction than either medicine can achieve alone at the same individual doses.

The 250mg/1.25mg strength is the lowest available Glucovance dose — specifically designed for initiating combination therapy in patients whose blood sugar is inadequately controlled on a single antidiabetic agent, or as a starting point for patients transitioning to dual-agent therapy. The low Glibenclamide dose of 1.25mg minimises hypoglycaemia risk during initiation while the Metformin component provides the metabolic and insulin-sensitising benefits that form the cornerstone of type 2 diabetes management.

Glucovance must always be taken with meals and used alongside dietary management and regular physical activity.

What Is Glucovance 250mg/1.25mg Used For?

Glucovance 250mg/1.25mg is prescribed for:

• Type 2 Diabetes Mellitus (ذیابیطس — شوگر) — as an adjunct to diet and exercise when blood sugar control is inadequate on a single antidiabetic medicine alone — either Metformin or a sulfonylurea used individually
• Second-line combination therapy — for patients already on maximum tolerated doses of Metformin alone or a sulfonylurea alone whose HbA1c and fasting blood glucose remain above target
• Initiation of dual antidiabetic therapy — the 250mg/1.25mg strength is the appropriate starting point for patients beginning Metformin-Glibenclamide combination therapy for the first time — allowing gradual dose escalation to higher strengths as needed
• Simplification of antidiabetic regimens — replacing separate Metformin and Glibenclamide tablets with a single fixed-dose combination tablet to improve convenience and treatment adherence

Glucovance is not indicated for Type 1 Diabetes, diabetic ketoacidosis, or as a first-line antidiabetic medicine in treatment-naive patients — it is a second-step combination therapy for inadequately controlled Type 2 Diabetes.

How Does Glucovance 250mg/1.25mg Work?

The clinical advantage of Glucovance lies in its simultaneous targeting of two distinct and complementary pathophysiological defects in type 2 diabetes:

Metformin Hydrochloride 250mg — Insulin Sensitiser and Hepatic Glucose Suppressor: Type 2 diabetes involves two core problems — the liver producing too much glucose even when blood sugar is already elevated, and peripheral tissues becoming resistant to insulin's signal to absorb glucose. Metformin addresses both simultaneously. By activating AMP-activated protein kinase (AMPK) in liver cells, it suppresses hepatic gluconeogenesis — reducing the liver's excessive glucose output that drives elevated fasting blood sugar. Simultaneously, it improves the sensitivity of muscle and fat cells to insulin — allowing them to absorb glucose more efficiently from the bloodstream. Critically, Metformin does not stimulate insulin secretion — meaning it does not cause hypoglycaemia when used alone and contributes no additional hypoglycaemia risk beyond the Glibenclamide component in this combination.

Glibenclamide (Glyburide) 1.25mg — Pancreatic Insulin Secretion Stimulator: Glibenclamide belongs to the sulfonylurea class — medicines that work by binding to specific ATP-sensitive potassium channels on the surface of pancreatic beta cells. This binding closes the potassium channels, triggering membrane depolarisation and opening of calcium channels — causing calcium influx that stimulates the beta cells to release stored insulin regardless of the prevailing blood glucose level. This insulin secretagogue effect directly addresses the beta cell dysfunction of type 2 diabetes — where the pancreas fails to produce adequate insulin in response to rising blood glucose. Glibenclamide is one of the most potent and longest-acting sulfonylureas — its insulin-stimulating effect persists for 16 to 24 hours, providing sustained postprandial and fasting glucose control throughout the day and night from a single or twice-daily dose.

Dual Complementary Action: Metformin reduces glucose supply (from the liver) and improves insulin efficiency (at peripheral tissues), while Glibenclamide increases insulin availability (from the pancreas). These mechanisms are additive and non-overlapping — targeting the hepatic, peripheral, and pancreatic components of type 2 diabetes simultaneously. Clinical studies consistently demonstrate that the Metformin-Glibenclamide combination achieves HbA1c reductions of 1.5 to 2.5% — significantly greater than either agent alone — making it one of the most effective oral antidiabetic combinations available.

Dosage and Administration

⚠️ Always take with meals — both to maximise Metformin tolerability and to time Glibenclamide's insulin release with food-driven glucose rise. Never skip a meal after taking Glucovance — the Glibenclamide component stimulates insulin release regardless of food intake, making missed meals a direct hypoglycaemia risk. Monitor blood glucose regularly. Inform your doctor before any surgery, CT scan with contrast, or procedure requiring fasting.

How to Take:

1. Swallow the tablet whole with a full glass of water
2. Always take with food — with breakfast for once-daily dosing, or with breakfast and evening meal for twice-daily dosing
3. Never skip or delay a meal after taking Glucovance — hypoglycaemia risk from Glibenclamide component
4. Take at consistent mealtimes each day to maintain predictable blood glucose control
5. If a dose is missed and the meal has passed, skip the missed dose — never double up at the next meal

Active Ingredients

Who Should NOT Take Glucovance 250mg/1.25mg?

Do not take Glucovance if you:

• Have Type 1 Diabetes — Glucovance is only for Type 2 Diabetes
• Have diabetic ketoacidosis — requires urgent insulin treatment
• Have significant kidney impairment — Metformin accumulates in renal failure causing lactic acidosis; eGFR must be assessed before prescribing
• Have severe liver disease — both components are contraindicated in significant hepatic impairment
• Are scheduled for surgery under general anaesthesia — stop Glucovance 48 hours before; restart only after kidney function is confirmed normal
• Are having a CT scan or angiogram with iodinated contrast dye — withhold 48 hours before and after due to Metformin lactic acidosis risk
• Have a condition causing tissue hypoxia — severe heart failure, respiratory failure, or recent heart attack
• Are allergic to Metformin, Glibenclamide, other sulfonylureas, or any ingredient in this product
• Are excessively using alcohol — increases both lactic acidosis and hypoglycaemia risk
• Are in the perioperative fasting period

Always consult your doctor before use if you:

• Have mild to moderate kidney impairment — dose adjustment and closer monitoring required
• Are elderly — higher hypoglycaemia risk from Glibenclamide; start at lowest dose with careful titration
• Are pregnant — insulin is the standard of care in pregnancy; oral antidiabetics require specialist assessment
• Are breastfeeding — Glibenclamide may pass into breast milk
• Have G6PD deficiency — sulfonylureas can cause haemolytic anaemia in G6PD-deficient patients
• Are taking other medicines that interact with sulfonylureas or Metformin — see interactions section

Side Effects

Common:

• Hypoglycaemia (شوگر کا گرنا) — the most clinically important side effect from the Glibenclamide component — sweating, trembling, dizziness, confusion, palpitations, weakness — always carry fast-acting glucose (sugar, glucose tablets) when taking Glucovance; risk is higher if meals are skipped, alcohol is consumed, or exercise is increased without dose adjustment
• Nausea, stomach discomfort, or diarrhoea — primarily from the Metformin component; reduced by always taking with food
• Metallic taste — recognised Metformin effect; usually fades with continued use
• Weight gain — sulfonylureas promote insulin secretion which stimulates fat storage; manage through dietary control
• Mild skin rash or itching — sulfonylurea-related; usually transient

Serious — Stop Use and Seek Emergency Medical Attention Immediately:

• Severe hypoglycaemia — loss of consciousness, seizure, or inability to swallow — administer glucagon injection if available or call emergency services immediately; Glibenclamide's prolonged action means hypoglycaemia can recur for many hours after treatment — hospital observation is often required (یہ طبی ہنگامی صورتحال ہے)
• Lactic acidosis — rare but life-threatening Metformin risk; symptoms: severe muscle pain, difficulty breathing, stomach pain, feeling cold, slow or irregular heartbeat — risk is very low with normal kidney function but escalates in renal failure, dehydration, or tissue hypoxia (یہ طبی ہنگامی صورتحال ہے)
• Haemolytic anaemia — rare sulfonylurea-related blood disorder in G6PD-deficient patients
• Significant liver effects — jaundice, severe fatigue, dark urine — rare with Glibenclamide
• Severe allergic reaction — rash, swelling of face or throat, difficulty breathing (یہ طبی ہنگامی صورتحال ہے)

Drug Interactions

Storage Instructions

• Store below 25°C in a cool, dry place
• Protect from moisture and direct sunlight
• Keep in original blister pack until use
• Keep out of reach of children (بچوں کی پہنچ سے دور رکھیں)
• Do not use after the expiry date on the pack or carton

Frequently Asked Questions

Why does Glucovance combine two different antidiabetic medicines — why not just increase one drug's dose?

Type 2 diabetes involves multiple simultaneous defects — excessive hepatic glucose production, peripheral insulin resistance, and inadequate pancreatic insulin secretion — that no single antidiabetic medicine addresses completely. Increasing the dose of one drug beyond a certain point produces diminishing returns in blood sugar lowering but progressively increases side effects. Combining Metformin and Glibenclamide at lower individual doses targets two completely separate mechanisms simultaneously — achieving greater total blood sugar reduction with a better side effect profile than maximising either drug alone. This pharmacological principle of complementary low-dose combination is why fixed-dose combinations like Glucovance are a standard approach in type 2 diabetes management when single-agent therapy is insufficient.

What are the signs of hypoglycaemia and what should I do if it happens?

 Hypoglycaemia — low blood sugar — from the Glibenclamide component typically presents as sweating, trembling, dizziness, weakness, palpitations, confusion, blurred vision, or an unusual feeling of hunger. If you experience these symptoms, immediately consume a fast-acting glucose source — 4 to 5 glucose tablets, a small glass of fruit juice, or 3 to 4 teaspoons of sugar dissolved in water. After recovery, eat a small snack containing complex carbohydrates such as a biscuit or bread to prevent recurrence. Glibenclamide is a long-acting sulfonylurea — hypoglycaemia can recur for many hours after initial treatment. Severe hypoglycaemia causing confusion or loss of consciousness is a medical emergency requiring glucagon injection or intravenous glucose — call emergency services immediately. Always carry fast-acting glucose with you at all times while taking Glucovance.

Why must Glucovance be stopped before a CT scan with contrast dye?

Iodinated contrast dye used in CT scans and angiograms can temporarily reduce kidney function — even in patients with previously normal kidneys. When kidney function is impaired, the Metformin component of Glucovance cannot be cleared from the blood normally, causing accumulation that significantly increases lactic acidosis risk. Standard clinical protocol requires stopping Glucovance — and all Metformin-containing medicines — 48 hours before any contrast imaging procedure and restarting only after kidney function has been confirmed normal 48 hours after the procedure. Always inform your radiologist, surgeon, and doctor that you are taking Glucovance before any procedure involving contrast dye or general anaesthesia.

Can I drink alcohol while taking Glucovance?

Alcohol should be avoided or strictly limited while taking Glucovance for two important reasons. First, alcohol enhances Glibenclamide's blood sugar-lowering effect — increasing the risk and severity of hypoglycaemia, while simultaneously impairing the body's ability to recover from low blood sugar by suppressing hepatic glucose production. Second, alcohol potentiates Metformin's effect on lactate metabolism — increasing lactic acidosis risk, particularly in patients who consume alcohol regularly or in large amounts. Even moderate alcohol consumption can cause unpredictable blood glucose swings in patients on sulfonylurea-containing regimens — making regular blood glucose monitoring essential if any alcohol is consumed.

How is Glucovance 250mg/1.25mg different from the higher-strength Glucovance tablets?

Glucovance is available in three strengths — 250mg/1.25mg, 500mg/2.5mg, and 500mg/5mg — each containing the same two active ingredients at progressively higher doses. The 250mg/1.25mg strength is the lowest dose, specifically designed for initiating combination therapy or for patients requiring only modest additional blood sugar control beyond their current single-agent treatment. As blood glucose targets require more aggressive management, the dose is escalated to 500mg/2.5mg and then 500mg/5mg — providing progressively stronger dual-mechanism blood sugar lowering. Your doctor will prescribe the strength and frequency that achieves your individual HbA1c target while maintaining an acceptable hypoglycaemia risk profile for your specific situation.

---

⚕️ Medical Disclaimer: This product description is for general informational purposes only and does not replace professional medical advice. Glucovance is a prescription combination antidiabetic — always use under the supervision of a qualified doctor. Always carry fast-acting glucose in case of hypoglycaemia. Never skip meals after taking this medicine. Stop before contrast procedures and surgery — restart only after medical clearance.

---

Prescription Required (Rx) | Always Take With Food | Never Skip Meals | Carry Fast-Acting Glucose at All Times | Stop Before Contrast Procedures & Surgery | Monitor Blood Glucose Regularly